NCT02035748View on ClinicalTrials.gov

Assessment of Patients Treated With JETREA® for Vitreomacular Traction

PHASE4CompletedINTERVENTIONAL
Enrollment

628

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Vitreomacular TractionVitreomacular Adhesion
Interventions
DRUG

Ocriplasmin

0.5 mg/0.2 mL solution for injection

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT02035748 - Assessment of Patients Treated With JETREA® for Vitreomacular Traction | Biotech Hunter | Biotech Hunter